---
title: "Herpesvirus Antibody Networks Linked to Autoimmunity and Chronic Disease"
id: "nature-immunology-0-herpesvirus-exposures-map-to-self-reactivity-networks-in-chronic-disease"
canonical_url: "https://medichelpline.com/clinical-feed/nature-immunology-0-herpesvirus-exposures-map-to-self-reactivity-networks-in-chronic-disease"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "Nature Immunology"
source_url: "https://www.nature.com/articles/s41590-026-02679-0"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Herpesvirus Antibody Networks Linked to Autoimmunity and Chronic Disease
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/nature-immunology-0-herpesvirus-exposures-map-to-self-reactivity-networks-in-chronic-disease
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** Nature Immunology
- **Source URL:** [Original Journal Publication](https://www.nature.com/articles/s41590-026-02679-0)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- Investigators profiled antiviral and self-reactive antibodies across two large biobank cohorts and mapped associations between **herpesvirus** exposures and human autoantigens. - The team used a multiplexed protein-display platform (the genome-scale DNA-barcoded library approach cited) to measure antibody reactivities to viral and human proteins simultaneously. - Data indicated convergent patterns: distinct virus-specific networks of autoreactivity were detectable, with some autoantigens forming dense, self-reactive hubs connected to herpesvirus seroreactivity. - The cohort analysis leveraged linked electronic health record data from a biobank resource to relate baseline antibody signatures to later disease outcomes. - Authors reported that these herpesvirus–autoantigen networks associate with future chronic disease diagnoses in the longitudinal dataset. - The briefing references prior work implicating **Epstein–Barr virus (EBV)** in multiple sclerosis and molecular mimicry between EBV antigens and human proteins; investigators noted similar mechanistic possibilities here. - The study draws on published platform methodology and a Mass General Brigham biobank resource; the Research Briefing did not include full numeric results, effect sizes, sample counts, or p-values in the summary. - The briefing describes figure-level evidence (scatter and chord-diagram visualizations) showing numbers and strengths of virus–autoantigen associations but does not reproduce statistical tables in the summary. - Authors and the briefing note potential biomarker implications: preclinical autoantibodies may mark later disease, but causal relationships were not established in the summary. - Limitations disclosed in the briefing include that the Research Briefing is a condensed summary of the full Lee et al. article; readers are referred to the primary open-access article for complete methods and detailed results.
## Clinical Analysis & Structured Key Points
## Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our [privacy policy](https://www.nature.com/info/privacy) for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies Reject optional cookies [Skip to main content](https://www.nature.com/articles/s41590-026-02679-0#content) Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement [ ![Nature Immunology](https://media.springernature.com/full/nature-cms/uploads/product/ni/header-ce329d5b570f961b651db20c364a103a.svg) ](https://www.nature.com/ni) * [ View all journals ](https://www.nature.com/siteindex) * [ Saved research ](https://www.nature.com/saved-research) * [ Search ](javascript:;) ## Search Search articles by subject, keyword or author Show results from All journals This journal Search [ Advanced search ](https://www.nature.com/search/advanced) ### Quick links * [Explore articles by subject](https://www.nature.com/subjects) * [Find a job](https://www.nature.com/naturecareers) * [Guide to authors](https://www.nature.com/authors/index.html) * [Editorial policies](https://www.nature.com/authors/editorial_policies/) * [Log in](https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41590-026-02679-0) * [ Content Explore content ](javascript:;) ## Explore content * [ Research articles ](https://www.nature.com/ni/research-articles) * [ Reviews & Analysis ](https://www.nature.com/ni/reviews-and-analysis) * [ News & Comment ](https://www.nature.com/ni/news-and-comment) * [ Videos ](https://www.nature.com/ni/video) * [ Current issue ](https://www.nature.com/ni/current-issue) * [ Collections ](https://www.nature.com/ni/collections) * [Follow us on X ](https://twitter.com/NatImmunol) * [ Subscribe ](https://www.nature.com/ni/subscribe) * [Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41590) * [ RSS feed ](https://www.nature.com/ni.rss) * [ About the journal ](javascript:;) ## About the journal * [ Aims & Scope ](https://www.nature.com/ni/aims) * [ Journal Information ](https://www.nature.com/ni/journal-information) * [ Editors ](https://www.nature.com/ni/editors) * [ Journal Metrics ](https://www.nature.com/ni/journal-impact) * [ Research Cross-Journal Editorial Team ](https://www.nature.com/ni/research-cross-journal-editorial-team) * [ Reviews Cross-Journal Editorial Team ](https://www.nature.com/ni/reviews-cross-journal-editorial-team) * [ Our publishing models ](https://www.nature.com/ni/our-publishing-models) * [ Editorial Values Statement ](https://www.nature.com/ni/editorial-values-statement) * [ Editorial Policies ](https://www.nature.com/ni/editorial-policies) * [ Content Types ](https://www.nature.com/ni/content) * [ Web Feeds ](https://www.nature.com/ni/web-feeds) * [ Posters ](https://www.nature.com/ni/posters) * [ Contact ](https://www.nature.com/ni/contact) * [ Publish with us ](javascript:;) ## Publish with us * [ Submission Guidelines ](https://www.nature.com/ni/submission-guidelines) * [ For Reviewers ](https://www.nature.com/ni/for-reviewers) * [ Language editing services ](https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022) * [Open access funding](https://www.nature.com/ni/open-access-funding) * [Submit manuscript ](https://mts-ni.nature.com/cgi-bin/main.plex) * [ Subscribe ](https://www.nature.com/ni/subscribe) * [ Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41590) * [ RSS feed ](https://www.nature.com/ni.rss) 1. [nature](https://www.nature.com/) 2. [nature immunology](https://www.nature.com/ni) 3. [research briefings](https://www.nature.com/ni/articles?type=research-briefing) 4. article * Research Briefing * Published: 20 November 2026 # Herpesvirus exposures map to self-reactivity networks in chronic disease [_Nature Immunology_](https://www.nature.com/ni) (2026) [Cite this article](https://www.nature.com/articles/s41590-026-02679-0#citeas) Save article [ View saved research ](https://www.nature.com/saved-research) Herpesviruses have long been linked to chronic disease, but how they interact with the immune system remains unclear. Comprehensive mapping of viral and human targets of antibody reactivity across two biobank cohorts identified distinct networks connecting herpesviruses to future disease, highlighting self-reactive hubs that may help to explain chronic disease. This is a preview of subscription content, [access via your institution](https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41590-026-02679-0) ## Access options [ Access through your institution ](https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41590-026-02679-0) Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 32.70 € / 30 days cancel any time [Learn more](https://shop.nature.com/products/plus/?region=ROW) Subscribe to this journal Receive 12 print issues and online access 251.40 € per year only 20.95 € per issue [Learn more](https://www.nature.com/ni/subscribe) Buy this article * Purchase on SpringerLink * Instant access to the full article PDF. 39,95 € Prices may be subject to local taxes which are calculated during checkout ### Additional access options: * [Log in](https://idp.nature.com/auth/personal/springernature?client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41590-026-02679-0) * [Learn about institutional subscriptions](https://www.springernature.com/gp/librarians/licensing/license-options) * [Read our FAQs](https://support.nature.com/en/support/home) * [Contact customer support](https://www.springernature.com/gp/contact) **Fig. 1: Herpesvirus reactivities converge on virus-specific patterns of autoreactivity.** ![The image presents two panels illustrating associations between herpesviruses and autoantigens. Panel a shows a scatter plot where each point represents an association between a specific herpesvirus and an autoantigen. The size of each diamond indicates the number of associations, ranging from one to over thirty, and the color intensity corresponds to the statistical significance measured by the negative logarithm of the false discovery rate. Panel b is a circular chord diagram mapping significant associations between herpesviruses and autoantigens, with the thickness of the line representing the number of associations and color intensity of connecting lines reflecting the strength of these associations. Autoantigens and viruses are labeled around the circle, with some autoantigens grouped or highlighted by specific labels. The diagrams collectively convey the pattern and strength of associations between different herpesviruses and a range of autoantigens.](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41590-026-02679-0/MediaObjects/41590_2026_2679_Fig1_HTML.png) ### Explore related subjects Discover the latest articles and news in related subjects. * [Autoimmune diseases](https://www.nature.com/subjects/autoimmune-diseases) * [Cancer](https://www.nature.com/subjects/cancer) * [Viral infection](https://www.nature.com/subjects/viral-infection) * [Molecular Characterization of Herpesviruses and Host Interactions](https://www.nature.com/subjects/molecular-characterization-of-herpesviruses-and-host-interactions) ## References 1. Bjornevik, K., Münz, C., Cohen, J. I. & Ascherio, A. Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. _Nat. Rev. Neurol._ **19** , 160–171 (2023). **A review of the causal evidence linking one herpesvirus to an autoimmune disease, and the mechanisms proposed.** [Article](https://doi.org/10.1038%2Fs41582-023-00775-5) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXjtFWgtLo%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36759741) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Epstein%E2%80%93Barr%20virus%20as%20a%20leading%20cause%20of%20multiple%20sclerosis%3A%20mechanisms%20and%20implications&journal=Nat.%20Rev.%20Neurol.&doi=10.1038%2Fs41582-023-00775-5&volume=19&pages=160-171&publication_year=2023&author=Bjornevik%2CK&author=M%C3%BCnz%2CC&author=Cohen%2CJI&author=Ascherio%2CA) 2. Credle, J. J. et al. Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries. _Nat. Biomed. Eng._ **6** , 992–1003 (2022). **This paper introduces the multiplexed protein display platform we used to simultaneously profile antiviral and self-directed antibodies.** [Article](https://doi.org/10.1038%2Fs41551-022-00925-y) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XisVagsr3I) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35986181) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034860) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Unbiased%20discovery%20of%20autoantibodies%20associated%20with%20severe%20COVID-19%20via%20genome-scale%20self-assembled%20DNA-barcoded%20protein%20libraries&journal=Nat.%20Biomed.%20Eng.&doi=10.1038%2Fs41551-022-00925-y&volume=6&pages=992-1003&publication_year=2022&author=Credle%2CJJ) 3. Castro, V. M. et al. The Mass General Brigham Biobank Portal: an i2b2-based data repository linking disparate and high-dimensional patient data to support multimodal analytics. _J. Am. Med. Inform. Assoc._ **29** , 643–651 (2022). **This study describes the biobank and linked EHR resource that enabled the longitudinal disease analysis.** [Article](https://doi.org/10.1093%2Fjamia%2Focab264) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34849976) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922162) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=The%20Mass%20General%20Brigham%20Biobank%20Portal%3A%20an%20i2b2-based%20data%20repository%20linking%20disparate%20and%20high-dimensional%20patient%20data%20to%20support%20multimodal%20analytics&journal=J.%20Am.%20Med.%20Inform.%20Assoc.&doi=10.1093%2Fjamia%2Focab264&volume=29&pages=643-651&publication_year=2022&author=Castro%2CVM) 4. Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. _Nature_ **603** , 321–327 (2022). **A landmark demonstration of molecular mimicry between a herpesvirus antigen and a human protein in autoimmune disease.** [Article](https://doi.org/10.1038%2Fs41586-022-04432-7) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xlsleisr4%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35073561) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382663) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Clonally%20expanded%20B%20cells%20in%20multiple%20sclerosis%20bind%20EBV%20EBNA1%20and%20GlialCAM&journal=Nature&doi=10.1038%2Fs41586-022-04432-7&volume=603&pages=321-327&publication_year=2022&author=Lanz%2CTV) 5. Leslie, D., Lipsky, P. & Notkins, A. L. Autoantibodies as predictors of disease. _J. Clin. Invest._ **108** , 1417–1422 (2001). **This paper establishes autoantibodies as detectable markers of preclinical disease, the premise for the biomarker implications.** [Article](https://doi.org/10.1172%2FJCI14452) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXosVyrtbk%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11714731) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC209428) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Autoantibodies%20as%20predictors%20of%20disease&journal=J.%20Clin.%20Invest.&doi=10.1172%2FJCI14452&volume=108&pages=1417-1422&publication_year=2001&author=Leslie%2CD&author=Lipsky%2CP&author=Notkins%2CAL) [Download references](https://citation-needed.springer.com/v2/references/10.1038/s41590-026-02679-0?format=refman&flavour=references) ## Additional information **Publisher’s note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. **This is a summary of:** Lee, S. et al. Large-scale antibody reactome profiling identifies herpesvirus-autoantigen associations that underlie chronic diseases. _Nat. Immunol_. (2026). J.A.L.-S. and N.P. used ChatGPT to help proofread their contribution to this Research Briefing. ## Rights and permissions [Reprints and permissions](https://s100.copyright.com/AppDispatchServlet?title=Herpesvirus%20exposures%20map%20to%20self-reactivity%20networks%20in%20chronic%20disease&author=&contentID=10.1038%2Fs41590-026-02679-0&copyright=Springer%20Nature%20America%2C%20Inc.&publication=1529-2908&publicationDate=2026-11-20&publisherName=SpringerNature&orderBeanReset=true) ## About this article [![Check for updates. Verify currency and authenticity via CrossMark](https://www.nature.com/articles/s41590-026-02679-0)](https://crossmark.crossref.org/dialog/?doi=10.1038/s41590-026-02679-0) ### Cite this article Herpesvirus exposures map to self-reactivity networks in chronic disease. _Nat Immunol_ (2026). https://doi.org/10.1038/s41590-026-02679-0 [Download citation](https://citation-needed.springer.com/v2/references/10.1038/s41590-026-02679-0?format=refman&flavour=citation) * Published: 20 November 2026 * Version of record: 20 November 2026 * DOI: https://doi.org/10.1038/s41590-026-02679-0 ### Share this article Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy shareable link to clipboard Provided by the Springer Nature SharedIt content-sharing initiative [ Access through your institution ](https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41590-026-02679-0) [ Buy or subscribe ](https://www.nature.com/articles/s41590-026-02679-0#access-options) ## Associated content ### [Large-scale antibody reactome profiling identifies herpesvirus–autoantigen associations that underlie chronic diseases](https://www.nature.com/articles/s41590-026-02674-5) * Sanghun Lee * Nicole Prince * Jessica A. Lasky-Su Nature Immunology Resource Open Access 20 Nov 2026 * Sections * Figures * References * [References](https://www.nature.com/articles/s41590-026-02679-0#Bib1) * [Additional information](https://www.nature.com/articles/s41590-026-02679-0#additional-information) * [Rights and permissions](https://www.nature.com/articles/s41590-026-02679-0#rightslink) * [About this article](https://www.nature.com/articles/s41590-026-02679-0#article-info) Advertisement * **Fig. 1: Herpesvirus reactivities converge on virus-specific patterns of autoreactivity.** 1. Bjornevik, K., Münz, C., Cohen, J. I. & Ascherio, A. Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. _Nat. Rev. Neurol._ **19** , 160–171 (2023). **A review of the causal evidence linking one herpesvirus to an autoimmune disease, and the mechanisms proposed.** [Article](https://doi.org/10.1038%2Fs41582-023-00775-5) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXjtFWgtLo%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36759741) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Epstein%E2%80%93Barr%20virus%20as%20a%20leading%20cause%20of%20multiple%20sclerosis%3A%20mechanisms%20and%20implications&journal=Nat.%20Rev.%20Neurol.&doi=10.1038%2Fs41582-023-00775-5&volume=19&pages=160-171&publication_year=2023&author=Bjornevik%2CK&author=M%C3%BCnz%2CC&author=Cohen%2CJI&author=Ascherio%2CA) 2. Credle, J. J. et al. Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries. _Nat. Biomed. Eng._ **6** , 992–1003 (2022). **This paper introduces the multiplexed protein display platform we used to simultaneously profile antiviral and self-directed antibodies.** [Article](https://doi.org/10.1038%2Fs41551-022-00925-y) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XisVagsr3I) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35986181) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034860) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Unbiased%20discovery%20of%20autoantibodies%20associated%20with%20severe%20COVID-19%20via%20genome-scale%20self-assembled%20DNA-barcoded%20protein%20libraries&journal=Nat.%20Biomed.%20Eng.&doi=10.1038%2Fs41551-022-00925-y&volume=6&pages=992-1003&publication_year=2022&author=Credle%2CJJ) 3. Castro, V. M. et al. The Mass General Brigham Biobank Portal: an i2b2-based data repository linking disparate and high-dimensional patient data to support multimodal analytics. _J. Am. Med. Inform. Assoc._ **29** , 643–651 (2022). **This study describes the biobank and linked EHR resource that enabled the longitudinal disease analysis.** [Article](https://doi.org/10.1093%2Fjamia%2Focab264) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34849976) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922162) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=The%20Mass%20General%20Brigham%20Biobank%20Portal%3A%20an%20i2b2-based%20data%20repository%20linking%20disparate%20and%20high-dimensional%20patient%20data%20to%20support%20multimodal%20analytics&journal=J.%20Am.%20Med.%20Inform.%20Assoc.&doi=10.1093%2Fjamia%2Focab264&volume=29&pages=643-651&publication_year=2022&author=Castro%2CVM) 4. Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. _Nature_ **603** , 321–327 (2022). **A landmark demonstration of molecular mimicry between a herpesvirus antigen and a human protein in autoimmune disease.** [Article](https://doi.org/10.1038%2Fs41586-022-04432-7) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xlsleisr4%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35073561) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382663) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Clonally%20expanded%20B%20cells%20in%20multiple%20sclerosis%20bind%20EBV%20EBNA1%20and%20GlialCAM&journal=Nature&doi=10.1038%2Fs41586-022-04432-7&volume=603&pages=321-327&publication_year=2022&author=Lanz%2CTV) 5. Leslie, D., Lipsky, P. & Notkins, A. L. Autoantibodies as predictors of disease. _J. Clin. In
## Related Clinical Research

- [Age-specific contact matrices across 28 EU/EEA countries during COVID-19: linking NPIs to social m](https://medichelpline.com/clinical-feed/medrxiv-21-reconstructing-age-specific-social-contact-patterns-across-28-eu-eea-countries.md)
- [Shamonda virus detected in a human for first time — French case under investigation](https://medichelpline.com/clinical-feed/stat-news-0-a-virus-that-afflicts-cows-makes-the-jump-to-a-human.md)
- [Severity-stratified cis-eQTL mapping identifies candidate causal genes for critical COVID-19](https://medichelpline.com/clinical-feed/medrxiv-9-severity-stratified-longitudinal-cis-eqtl-mapping-enables-high-sensitivity.md)
- [Why some people have stronger vaccine side effects: immune signaling and what to do](https://medichelpline.com/clinical-feed/medical-news-today-0-vaccines-why-some-of-us-are-more-likely-to-experience-side-effects-and-what-to.md)
- [Fauci on pandemic memory: selective amnesia and its effect on views of masking and lockdowns](https://medichelpline.com/clinical-feed/stat-news-1-stat-fauci-speaks-and-writes.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.